PMC:7247521 / 10483-10833 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"155","span":{"begin":6,"end":10},"obj":"Gene"},{"id":"156","span":{"begin":30,"end":33},"obj":"Species"},{"id":"159","span":{"begin":40,"end":48},"obj":"Disease"},{"id":"160","span":{"begin":57,"end":71},"obj":"Disease"},{"id":"161","span":{"begin":73,"end":91},"obj":"Disease"},{"id":"162","span":{"begin":104,"end":112},"obj":"Disease"},{"id":"182","span":{"begin":227,"end":231},"obj":"Species"},{"id":"184","span":{"begin":176,"end":184},"obj":"Disease"},{"id":"185","span":{"begin":194,"end":202},"obj":"Disease"},{"id":"186","span":{"begin":305,"end":313},"obj":"Disease"}],"attributes":[{"id":"A155","pred":"tao:has_database_id","subj":"155","obj":"Gene:2078"},{"id":"A156","pred":"tao:has_database_id","subj":"156","obj":"Tax:10116"},{"id":"A159","pred":"tao:has_database_id","subj":"159","obj":"MESH:D064420"},{"id":"A160","pred":"tao:has_database_id","subj":"160","obj":"MESH:D056486"},{"id":"A161","pred":"tao:has_database_id","subj":"161","obj":"MESH:D012871"},{"id":"A162","pred":"tao:has_database_id","subj":"162","obj":"MESH:D064420"},{"id":"A182","pred":"tao:has_database_id","subj":"182","obj":"Tax:2697049"},{"id":"A184","pred":"tao:has_database_id","subj":"184","obj":"MESH:C000657245"},{"id":"A185","pred":"tao:has_database_id","subj":"185","obj":"MESH:C000657245"},{"id":"A186","pred":"tao:has_database_id","subj":"186","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"itor, hERG II inhibitor, oral rat acute toxicity (LD50), hepatotoxicity, skin sensitisation, and minnow toxicity).\n\n2.6 Molecular docking\nTo facilitate drug discovery against COVID-19, we used COVID-19 Docking Server (https://ncov.schanglab.org.cn/index.php) [23] to predict the binding modes between 12 COVID-19 targets and the 20 lead-likeness of "}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T110","span":{"begin":6,"end":10},"obj":"PR:P11308"},{"id":"T111","span":{"begin":14,"end":23},"obj":"CHEBI:35222;CHEBI:35222"},{"id":"T112","span":{"begin":25,"end":29},"obj":"UBERON:0000165"},{"id":"T113","span":{"begin":30,"end":33},"obj":"NCBITaxon:10114"},{"id":"T114","span":{"begin":153,"end":157},"obj":"CHEBI:23888;CHEBI:23888"},{"id":"T115","span":{"begin":176,"end":184},"obj":"SP_7"},{"id":"T116","span":{"begin":194,"end":202},"obj":"SP_7"},{"id":"T117","span":{"begin":305,"end":313},"obj":"SP_7"}],"text":"itor, hERG II inhibitor, oral rat acute toxicity (LD50), hepatotoxicity, skin sensitisation, and minnow toxicity).\n\n2.6 Molecular docking\nTo facilitate drug discovery against COVID-19, we used COVID-19 Docking Server (https://ncov.schanglab.org.cn/index.php) [23] to predict the binding modes between 12 COVID-19 targets and the 20 lead-likeness of "}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T18","span":{"begin":73,"end":77},"obj":"Body_part"}],"attributes":[{"id":"A18","pred":"fma_id","subj":"T18","obj":"http://purl.org/sig/ont/fma/fma7163"}],"text":"itor, hERG II inhibitor, oral rat acute toxicity (LD50), hepatotoxicity, skin sensitisation, and minnow toxicity).\n\n2.6 Molecular docking\nTo facilitate drug discovery against COVID-19, we used COVID-19 Docking Server (https://ncov.schanglab.org.cn/index.php) [23] to predict the binding modes between 12 COVID-19 targets and the 20 lead-likeness of "}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T13","span":{"begin":73,"end":77},"obj":"Body_part"}],"attributes":[{"id":"A13","pred":"uberon_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/UBERON_0000014"}],"text":"itor, hERG II inhibitor, oral rat acute toxicity (LD50), hepatotoxicity, skin sensitisation, and minnow toxicity).\n\n2.6 Molecular docking\nTo facilitate drug discovery against COVID-19, we used COVID-19 Docking Server (https://ncov.schanglab.org.cn/index.php) [23] to predict the binding modes between 12 COVID-19 targets and the 20 lead-likeness of "}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T34","span":{"begin":176,"end":184},"obj":"Disease"},{"id":"T35","span":{"begin":194,"end":202},"obj":"Disease"},{"id":"T36","span":{"begin":305,"end":313},"obj":"Disease"}],"attributes":[{"id":"A34","pred":"mondo_id","subj":"T34","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A35","pred":"mondo_id","subj":"T35","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A36","pred":"mondo_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"itor, hERG II inhibitor, oral rat acute toxicity (LD50), hepatotoxicity, skin sensitisation, and minnow toxicity).\n\n2.6 Molecular docking\nTo facilitate drug discovery against COVID-19, we used COVID-19 Docking Server (https://ncov.schanglab.org.cn/index.php) [23] to predict the binding modes between 12 COVID-19 targets and the 20 lead-likeness of "}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T82","span":{"begin":73,"end":77},"obj":"http://purl.obolibrary.org/obo/UBERON_0000014"},{"id":"T83","span":{"begin":73,"end":77},"obj":"http://purl.obolibrary.org/obo/UBERON_0001003"},{"id":"T84","span":{"begin":73,"end":77},"obj":"http://purl.obolibrary.org/obo/UBERON_0002097"},{"id":"T85","span":{"begin":73,"end":77},"obj":"http://purl.obolibrary.org/obo/UBERON_0002199"},{"id":"T86","span":{"begin":73,"end":77},"obj":"http://www.ebi.ac.uk/efo/EFO_0000962"}],"text":"itor, hERG II inhibitor, oral rat acute toxicity (LD50), hepatotoxicity, skin sensitisation, and minnow toxicity).\n\n2.6 Molecular docking\nTo facilitate drug discovery against COVID-19, we used COVID-19 Docking Server (https://ncov.schanglab.org.cn/index.php) [23] to predict the binding modes between 12 COVID-19 targets and the 20 lead-likeness of "}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T46","span":{"begin":11,"end":13},"obj":"Chemical"},{"id":"T47","span":{"begin":14,"end":23},"obj":"Chemical"},{"id":"T48","span":{"begin":153,"end":157},"obj":"Chemical"}],"attributes":[{"id":"A46","pred":"chebi_id","subj":"T46","obj":"http://purl.obolibrary.org/obo/CHEBI_74067"},{"id":"A47","pred":"chebi_id","subj":"T47","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A48","pred":"chebi_id","subj":"T48","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"itor, hERG II inhibitor, oral rat acute toxicity (LD50), hepatotoxicity, skin sensitisation, and minnow toxicity).\n\n2.6 Molecular docking\nTo facilitate drug discovery against COVID-19, we used COVID-19 Docking Server (https://ncov.schanglab.org.cn/index.php) [23] to predict the binding modes between 12 COVID-19 targets and the 20 lead-likeness of "}

{"project":"LitCovid-sentences","denotations":[{"id":"T66","span":{"begin":116,"end":138},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"itor, hERG II inhibitor, oral rat acute toxicity (LD50), hepatotoxicity, skin sensitisation, and minnow toxicity).\n\n2.6 Molecular docking\nTo facilitate drug discovery against COVID-19, we used COVID-19 Docking Server (https://ncov.schanglab.org.cn/index.php) [23] to predict the binding modes between 12 COVID-19 targets and the 20 lead-likeness of "}